A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
- NCT ID
- NCT07403188
- Registry status
- Recruiting
- Study type
- Observational
- Sponsor
- Kyverna Therapeutics
- Conditions
- Dermatomyositis, Multiple Sclerosis, Myasthaenia Gravis, Refractory Lupus Nephritis, Rheumatoid Arthritis (RA), Stiff Person Syndrome, Systemic Sclerosis (SSc)
Overview
ClinicalTrials.gov lists this study as Recruiting.
Enrollment: 70 participants (Estimated).
What is being studied
- Drug: KYV-101
Who may be eligible
- Ages
- 18 Years to no maximum
- Sex
- All
- Healthy volunteers accepted
- No
ClinicalTrials.gov lists the following eligibility criteria.
Inclusion Criteria:
* Provided informed consent for the LTFU study
* Received at least 1 infusion of KYV-101 as part of a previous KYV-101 parent treatment protocol
Exclusion Criteria:
* Not applicable
Study locations
1 study location is listed.
Recruiting site status is explicitly provided for 1 location; 1 is listed as Recruiting.
Countries: United States
- Colorado, United States: 1
Sample of listed locations
- University of Colorado, Denver — Denver, Colorado, 80045, United States — Recruiting
Study details
- Start date
- November 24, 2025
- Primary completion date
- January 1, 2041
- Completion date
- January 1, 2041
- First posted
- February 11, 2026
Source and update information
- Source
- ClinicalTrials.gov
- NCT ID
- NCT07403188
- Registry last updated
- February 11, 2026
- QualifiedStudies registry data refreshed
- October 2, 2026
- QualifiedStudies record fetched
- October 2, 2026
View NCT07403188 on ClinicalTrials.gov
Trial information can change. Confirm current study details with the study team or the registry.
About joining clinical research
Find clinical trials you may match with
QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.
Find clinical trials you may match with | Clinical trial FAQ